InsiderClue
Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

Insight Molecular Diagnostics Inc.

IMDX Clue Score47
United States Fiscal year ends December CIK 0001642380
$3.37 +2.74% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $3.37 +0.60% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Operating income−11.1Net income−11.2Fiscal year 2017Operating income−18.8Net income−19.4Fiscal year 2018Operating income−15.2Net income−15.8Fiscal year 2019Operating income−22.2Net income−22.4Fiscal year 2020Revenue1.2Operating income−29.7Net income−29.9Fiscal year 2021Revenue2.2 +80.8%Operating income−53.7Net income−64.1Fiscal year 2022Revenue1.0 −56.4%Operating income−18.0Net income−72.9EPS, diluted−13.25Fiscal year 2023Revenue1.5 +56.9%Operating income−25.1Net income−27.8EPS, diluted−3.75Fiscal year 2024Revenue1.9 +25.1%Operating income−61.0Net income−60.7EPS, diluted−4.66Fiscal year 2025Revenue4.1 +115.6%Operating income−51.1Net income−50.2EPS, diluted−1.65
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a n/a n/a 1.2 2.2 1.0 1.5 1.9 4.1
Growth +80.8% −56.4% +56.9% +25.1% +115.6%
Operating income −11.1 −18.8 −15.2 −22.2 −29.7 −53.7 −18.0 −25.1 −61.0 −51.1
Net income −11.2 −19.4 −15.8 −22.4 −29.9 −64.1 −72.9 −27.8 −60.7 −50.2
Growth
EPS, diluted n/a n/a n/a n/a n/a n/a −13.25 −3.75 −4.66 −1.65

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Fiscal year 2017Fiscal year 2018Fiscal year 2019Fiscal year 2020Gross margin−52.5%Operating margin−2,443.3%Net margin−2,461.5%Free cash flow margin−2,237.4%Fiscal year 2021Gross margin64.6%Operating margin−2,444.3%Net margin−2,916.2%Free cash flow margin−1,737.4%Fiscal year 2022Gross margin−1.9%Operating margin−1,878.6%Net margin−7,609.8%Free cash flow margin−5,209.6%Fiscal year 2023Gross margin27.5%Operating margin−1,672.4%Net margin−1,848.4%Free cash flow margin−1,570.6%Fiscal year 2024Gross margin39.3%Operating margin−3,245.1%Net margin−3,225.0%Free cash flow margin−1,127.3%Fiscal year 2025Gross margin56.7%Operating margin−1,260.8%Net margin−1,238.5%Free cash flow margin−625.6%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a n/a n/a n/a −52.5% 64.6% −1.9% 27.5% 39.3% 56.7%
Operating margin n/a n/a n/a n/a −2,443.3% −2,444.3% −1,878.6% −1,672.4% −3,245.1% −1,260.8%
Net margin n/a n/a n/a n/a −2,461.5% −2,916.2% −7,609.8% −1,848.4% −3,225.0% −1,238.5%
Free cash flow margin n/a n/a n/a n/a −2,237.4% −1,737.4% −5,209.6% −1,570.6% −1,127.3% −625.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−7.5Capital expenditure−0.1Free cash flow−7.6Fiscal year 2017Operating cash flow−13.4Capital expenditure−0.1Free cash flow−13.5Fiscal year 2018Operating cash flow−11.6Capital expenditure−0.0Free cash flow−11.7Fiscal year 2019Operating cash flow−19.7Capital expenditure−0.9Free cash flow−20.6Fiscal year 2020Operating cash flow−26.0Capital expenditure−1.2Free cash flow−27.2Fiscal year 2021Operating cash flow−35.9Capital expenditure−2.2Free cash flow−38.2Fiscal year 2022Operating cash flow−45.6Capital expenditure−4.3Free cash flow−49.9Fiscal year 2023Operating cash flow−23.3Capital expenditure−0.3Free cash flow−23.6Fiscal year 2024Operating cash flow−20.7Capital expenditure−0.5Free cash flow−21.2Fiscal year 2025Operating cash flow−22.2Capital expenditure−3.2Free cash flow−25.4
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −7.5 −13.4 −11.6 −19.7 −26.0 −35.9 −45.6 −23.3 −20.7 −22.2
Capital expenditure −0.1 −0.1 −0.0 −0.9 −1.2 −2.2 −4.3 −0.3 −0.5 −3.2
Free cash flow −7.6 −13.5 −11.7 −20.6 −27.2 −38.2 −49.9 −23.6 −21.2 −25.4
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash10.2Shareholders’ equity9.9Fiscal year 2017Cash7.6Total debt1.9Net cash (debt)5.7Shareholders’ equity4.4Debt to equity0.42Fiscal year 2018Cash8.0Shareholders’ equity3.4Fiscal year 2019Cash22.1Shareholders’ equity30.8Fiscal year 2020Cash7.1Shareholders’ equity33.5Fiscal year 2021Cash32.9Shareholders’ equity65.2Fiscal year 2022Cash20.0Shareholders’ equity34.3Fiscal year 2023Cash9.4Shareholders’ equity20.5Fiscal year 2024Cash8.6Shareholders’ equity−12.3Fiscal year 2025Cash11.6Shareholders’ equity−31.5
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 10.2 7.6 8.0 22.1 7.1 32.9 20.0 9.4 8.6 11.6
Total debt n/a 1.9 n/a n/a n/a n/a n/a n/a n/a n/a
Net cash (debt) n/a 5.7 n/a n/a n/a n/a n/a n/a n/a n/a
Shareholders’ equity 9.9 4.4 3.4 30.8 33.5 65.2 34.3 20.5 −12.3 −31.5
Debt to equity n/a 0.42 n/a n/a n/a n/a n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024† 31 Dec 2024 FY2025† 31 Dec 2025
Revenue and profit
n/a n/a n/a n/a 1.2 2.2 1.0 1.5 1.9 4.1
Growth +80.8% −56.4% +56.9% +25.1% +115.6%
n/a n/a n/a n/a 1.9 0.7 0.9 1.0 1.1 1.8
n/a n/a n/a n/a −0.6 1.4 −0.0 0.4 0.7 2.3
Growth −101.3% +79.2% +210.5%
5.7 7.2 6.5 6.8 9.8 5.0 7.3 9.3 9.8 15.9
4.3 9.2 7.0 13.3 16.8 22.3 21.9 11.2 10.2 10.6
−11.1 −18.8 −15.2 −22.2 −29.7 −53.7 −18.0 −25.1 −61.0 −51.1
Growth
n/a n/a n/a −22.4 −31.2 −52.9 −18.6 −24.9 −60.7 n/a
n/a n/a n/a n/a −1.3 −9.3 n/a 0.0 0.0 0.0
−11.2 −19.4 −15.8 −22.4 −29.9 −64.1 −72.9 −27.8 −60.7 −50.2
Growth
Per share
n/a n/a n/a n/a n/a −0.72 −13.25 −3.75 −4.66 −1.65
n/a n/a n/a n/a n/a n/a −13.25 −3.75 −4.66 −1.65
Growth
n/a n/a n/a n/a n/a 0.1 5.5 7.7 13.1 30.5
n/a n/a n/a n/a n/a n/a 5.5 7.7 13.1 30.5
Growth +38.1% +70.8% +133.2%

† The diluted share count jumps at 2024 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 27.2% a year over five years.
  • Operating margin is up 1,182.6 points on five years ago, at -1,260.8%.
  • A net loss in 10 of 10 years on file.